+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Independent Diagnostic Testing Facility Market Size, Share & Trends Analysis Report by Service, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 100 Pages
  • January 2026
  • Region: United States
  • Grand View Research
  • ID: 6227975
The U.S. independent diagnostic testing facility market size was estimated at USD 10.08 billion in 2025 and is projected to reach USD 18.09 billion by 2033, growing at a CAGR of 7.66% from 2026 to 2033. The growth is driven by the growing burden of chronic and lifestyle-related diseases, rising preference for cost-efficient, accessible, and faster diagnostics, and increasing technological advancements, including digital imaging, AI-enabled diagnostics, portable diagnostics, and improved telehealth integration.

In addition, value-based healthcare initiatives and supportive reimbursement structures for certain diagnostic procedures are encouraging providers to shift services to independent diagnostic testing facilities.

U.S. Independent Diagnostic Testing Facility Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. independent diagnostic testing facility market report based on service:

Service Outlook (Revenue, USD Million, 2021-2033)

  • Radiology/Imaging Services
  • Sleep Studies
  • Cardiac Monitoring Services

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Independent Diagnostic Testing Facility Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Service segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Dynamics
3.2.1.1. Market Driver Analysis
3.2.1.2. Market Restraint Analysis
3.2.1.3. Market Opportunities Analysis
3.2.1.4. Market Challenges Analysis
3.3. Regulatory Framework
3.4. Business Environment Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces Analysis
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
Chapter 4. Service Business Analysis
4.1. U.S. Independent Diagnostic Testing Facility Market: Service Movement Analysis
4.2. U.S. Independent Diagnostic Testing Facility Market: Service Segment Dashboard
4.3. Service Movement & Market Share Analysis, 2025 & 2033
4.4. U.S. Independent Diagnostic Testing Facility Market Estimates & Forecast, by Service
4.5. Radiology/Imaging Services
4.5.1. Radiology/imaging services market, 2021-2033 (USD Million)
4.5.2. X-Ray
4.5.2.1. X-ray market, 2021-2033 (USD Million)
4.5.3. Computed Tomography (CT)
4.5.3.1. Computed tomography (CT) market, 2021-2033 (USD Million)
4.5.4. Magnetic Resonance Angiography (MRA)
4.5.4.1. Magnetic resonance angiography (MRA) market, 2021-2033 (USD Million)
4.5.5. Magnetic Resonance Imaging (MRI)
4.5.5.1. Magnetic resonance imaging (MRI) market, 2021-2033 (USD Million)
4.5.6. Mammography
4.5.6.1. Mammography market, 2021-2033 (USD Million)
4.5.7. Ultrasound
4.5.7.1. Ultrasound market, 2021-2033 (USD Million)
4.5.8. Position Emission Tomography (PET) Scan
4.5.8.1. Position emission tomography (PET) scan market, 2021-2033 (USD Million)
4.6. Sleep Studies
4.6.1. Sleep studies market, 2021-2033 (USD Million)
4.7. Cardiac Monitoring Services
4.7.1. Cardiac monitoring services market, 2021-2033 (USD Million)
Chapter 5. Company Landscape
5.1. Company Categorization
5.2. Company Market Position Analysis, 2025
5.3. Strategy Mapping
5.4. Company Profiles/Listing
5.4.1. RadNet, Inc.
5.4.1.1. Overview
5.4.1.2. Financial performance
5.4.1.3. Service benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Vitalistics
5.4.2.1. Overview
5.4.2.2. Financial performance
5.4.2.3. Service benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Breathe
5.4.3.1. Overview
5.4.3.2. Financial performance
5.4.3.3. Service benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Texas MRI
5.4.4.1. Overview
5.4.4.2. Financial performance
5.4.4.3. Service benchmarking
5.4.4.4. Strategic initiatives
5.4.5. The Brookwood Diagnostic Center
5.4.5.1. Overview
5.4.5.2. Financial performance
5.4.5.3. Service benchmarking
5.4.5.4. Strategic initiatives
5.4.6. ACS Diagnostics, Inc.
5.4.6.1. Overview
5.4.6.2. Financial performance
5.4.6.3. Service benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Houston MRI & Diagnostic Imaging
5.4.7.1. Overview
5.4.7.2. Financial performance
5.4.7.3. Service benchmarking
5.4.7.4. Strategic initiatives
5.4.8. TestSmarter Inc.
5.4.8.1. Overview
5.4.8.2. Financial performance
5.4.8.3. Service benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Duke University and Duke University Health System
5.4.9.1. Overview
5.4.9.2. Financial performance
5.4.9.3. Service benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Covenant Health Diagnostics
5.4.10.1. Overview
5.4.10.2. Financial performance
5.4.10.3. Service benchmarking
5.4.10.4. Strategic initiatives
5.4.11. AliveCor, Inc.
5.4.11.1. Overview
5.4.11.2. Financial performance
5.4.11.3. Service benchmarking
5.4.11.4. Strategic initiatives
5.4.12. Advanced Cardio Services
5.4.12.1. Overview
5.4.12.2. Financial performance
5.4.12.3. Service benchmarking
5.4.12.4. Strategic initiatives
5.4.13. Diagnostic Medical Testing Inc.
5.4.13.1. Overview
5.4.13.2. Financial performance
5.4.13.3. Service benchmarking
5.4.13.4. Strategic initiatives
5.4.14. K & T Diagnostic, Inc.
5.4.14.1. Overview
5.4.14.2. Financial performance
5.4.14.3. Service benchmarking
5.4.14.4. Strategic initiatives
5.4.15. Vestavia Diagnostic Center (VDC)
5.4.15.1. Overview
5.4.15.2. Financial performance
5.4.15.3. Service benchmarking
5.4.15.4. Strategic initiatives
5.4.16. Advanced Imaging Center
5.4.16.1. Overview
5.4.16.2. Financial performance
5.4.16.3. Service benchmarking
5.4.16.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. independent diagnostic testing facility market revenue estimates and forecast, by service, 2021-2033 (USD Million)
List of Figures
Figure 1 U.S. independent diagnostic testing facility market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Competitive landscape
Figure 11 U.S. independent diagnostic testing facility market trends & outlook
Figure 12 Market driver relevance analysis (Current & future impact)
Figure 13 Market restraint relevance analysis (Current & future impact)
Figure 14 Penetration & growth prospect mapping
Figure 15 U.S. independent diagnostic testing facility market: Service movement share analysis (USD Million)
Figure 16 U.S independent diagnostic testing facility service market: Segment dashboard
Figure 17 Radiology/Imaging testing market, 2021-2033 (USD Million)
Figure 18 X-Ray market, 2021-2033 (USD Million)
Figure 19 Computed tomography (CT) market, 2021-2033 (USD Million)
Figure 20 Magnetic resonance angiography (MRA) market, 2021-2033 (USD Million)
Figure 21 Magnetic resonance imaging (MRI) market, 2021-2033 (USD Million)
Figure 22 Mammography market, 2021-2033 (USD Million)
Figure 23 Ultrasound market, 2021-2033 (USD Million)
Figure 24 Positron emission tomography (PET) Scan. 2021-2033 (USD Million)
Figure 25 Sleep studies market, 2021-2033 (USD Million)
Figure 26 Cardiac monitoring services market, 2021-2033 (USD Million)
Figure 27 Competition categorization
Figure 28 Company market position analysis, 2025
Figure 29 Strategic framework

Companies Mentioned

The leading players profiled in this U.S. Independent Diagnostic Testing Facility market report include:
  • RadNet, Inc.
  • Vitalistics
  • Breathe
  • Texas MRI
  • The Brookwood Diagnostic Center
  • ACS Diagnostics, Inc.
  • Houston MRI & Diagnostic Imaging
  • TestSmarter Inc.
  • Duke University and Duke University Health System
  • Covenant Health Diagnostics
  • AliveCor, Inc.
  • Advanced Cardio Services
  • Diagnostic Medical Testing Inc.
  • K & T Diagnostic, Inc.
  • Vestavia Diagnostic Center (VDC)
  • Advanced Imaging Center

Table Information